These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7756750)

  • 1. Novel pseudopeptides with high affinities for the human bradykinin B2 receptor.
    Chakravarty S; Connolly M; Kyle DJ
    Pept Res; 1995; 8(1):16-9. PubMed ID: 7756750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of pseudopeptide bradykinin B2 receptor antagonists containing the 1,3,8-triazaspiro[4.5]decan-4-one ring system.
    Mavunkel BJ; Lu Z; Goehring RR; Lu S; Chakravarty S; Perumattam J; Novotny EA; Connolly M; Valentine H; Kyle DJ
    J Med Chem; 1996 Aug; 39(16):3169-73. PubMed ID: 8759638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor.
    Fathy DB; Kyle DJ; Leeb-Lundberg LM
    Mol Pharmacol; 2000 Jan; 57(1):171-9. PubMed ID: 10617692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
    Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
    J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the bradykinin B2 receptors' amino terminus.
    AbdAlla S; Godovac-Zimmermann J; Braun A; Roscher AA; Müller-Esterl W; Quitterer U
    Biochemistry; 1996 Jun; 35(23):7514-9. PubMed ID: 8652530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
    J Med Chem; 1998 Nov; 41(23):4587-98. PubMed ID: 9804698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New conformationally homogeneous beta-turn antagonists of the human B2 kinin receptor.
    Monteagudo ES; Calvani F; Catrambone F; Fincham CI; Madami A; Meini S; Terracciano R
    J Pept Sci; 2001 May; 7(5):270-83. PubMed ID: 11428548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
    Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
    Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moiety.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
    J Med Chem; 1998 Oct; 41(21):4062-79. PubMed ID: 9767643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
    Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D
    Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 2. Overcoming the species difference between guinea pig and man.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Hatori C; Sawai H; Oku T; Tanaka H
    J Med Chem; 1998 Oct; 41(21):4053-61. PubMed ID: 9767642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and pharmacological characterization of the canine B1 and B2 bradykinin receptors.
    Hess JF; Hey PJ; Chen TB; O'Brien J; Omalley SS; Pettibone DJ; Chang RS
    Biol Chem; 2001 Jan; 382(1):123-9. PubMed ID: 11258662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human vascular kinin receptors of the B2 type characterized by radioligand binding.
    Gessi S; Rizzi A; Calò G; Agnello G; Jorizzo G; Mollica G; Borea PA; Regoli D
    Br J Pharmacol; 1997 Dec; 122(7):1450-4. PubMed ID: 9421294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative NMR and molecular dynamics study of the conformations of bradykinin B1 and B2, B2, and B1-specific receptor antagonists B-9430, B-9436, and B-9858.
    Sejbal J; Wang Y; Cann JR; Stewart JM; Gera L; Kotovych G
    Biopolymers; 1997 Oct; 42(5):521-35. PubMed ID: 9322442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential pharmacology of cloned human and mouse B2 bradykinin receptors.
    Hess JF; Borkowski JA; Macneil T; Stonesifer GY; Fraher J; Strader CD; Ransom RW
    Mol Pharmacol; 1994 Jan; 45(1):1-8. PubMed ID: 8302267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue.
    Liebmann C; Bossé R; Escher E
    Mol Pharmacol; 1994 Nov; 46(5):949-56. PubMed ID: 7969085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of aspartate residues in the third extracellular loop of the rat B2 bradykinin receptor decreases affinity for bradykinin.
    Novotny EA; Bednar DL; Connolly MA; Connor JR; Stormann TM
    Biochem Biophys Res Commun; 1994 Jun; 201(2):523-30. PubMed ID: 8002982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Imai K; Inamura N; Asano M; Hatori C; Katayama A; Oku T; Tanaka H
    J Med Chem; 1998 Feb; 41(4):564-78. PubMed ID: 9484506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proton magnetic resonance study of two synthetic agonist-antagonist pairs of bradykinin analogues.
    Otter A; Bigler P; Stewart JM; Kotovych G
    Biopolymers; 1993 May; 33(5):769-80. PubMed ID: 8393713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.